Testosterone therapy is a long-term commitment with a defined safety profile, and the clinic you choose determines whether that profile is managed or ignored. The molecule is the same everywhere. What differs is the panel drawn before the first prescription, the causes ruled out, the contraindications screened, and the monitoring scheduled after.
Cost differences follow from those choices rather than from the drug. Generic injectable testosterone runs $30–$100 a month at any pharmacy. Everything above that is diagnostics and clinical time. This page compares the physician-led programs on the same rubric, then sets out what to check regardless of which one you use.
The Verdict
The six physician-led programs, alphabetically
Listed alphabetically by name. Ordering carries no editorial meaning. Prices are self-pay ranges published or commonly reported at the time of review, and exclude medication unless stated. Each program also has a full review on this site against the standard ten-row rubric.
| Program | Price | Model | Prescription pathway | Labs | Fits |
|---|---|---|---|---|---|
| Fountain Life | $19,500+/yr | In-person concierge, imaging-led | Hormone therapy inside a full diagnostic program | Included in the membership | Men who want imaging and in-person clinician days alongside hormone care |
| Hone Health | ~$540–$2,640/yr | Telehealth, men's hormone focus | Testosterone; ancillaries where indicated | At-home collection plus lab draws | Men who want a hormone-focused program at the lowest entry price |
| Lifeforce | ~$1,900/yr | Telehealth optimization, clinician-led | Testosterone, peptides, GLP-1 | Bundled panel with scheduled retests | Men who want hormones inside a broader optimization program |
| Marek Health | $2,500–$6,000/yr all-in | Telehealth, hormone and lab depth | Testosterone, hCG, SERMs, peptides, ancillaries | A la carte — cost scales with how much you order | Men who want a wide lab menu and are comfortable directing it |
| Maximus | ~$1,800–$3,600/yr plus labs | Telehealth, men's hormone focus | Enclomiphene, testosterone | Labs generally billed separately | Men prioritizing fertility preservation via a SERM-first protocol |
| Opt Health | ~$3,000/yr | Telehealth optimization, physician-led | Testosterone, peptides, GLP-1 | Bundled panel with scheduled retests | Men who want hormones read against a wider panel |
First-mention official sites, alphabetically: Fountain Life, Hone Health, Lifeforce, Marek Health, Maximus, Opt Health.
The eight signals that separate a protocol from a subscription
These apply to every program in the table and to any local clinic. They are the same signals a competent endocrinologist would apply, restated as things a patient can check.
| Signal | What a rigorous program does | What a prescription mill does |
|---|---|---|
| The baseline panel | Total and free testosterone, SHBG, LH, FSH, sensitive estradiol, prolactin, PSA, CBC, metabolic panel, full thyroid | Total testosterone alone, or a symptom questionnaire with one number |
| Draw conditions | Before 10am, on two separate days, off high-dose biotin, not during acute illness | One draw, any time of day, then a same-visit prescription |
| Reversible causes | Sleep apnea, body composition, opioids, glucocorticoids, alcohol, thyroid and iron studies addressed first | No discussion of anything except the hormone |
| Fertility | Raised before the first dose; sperm banking, hCG or a SERM alternative offered | Never mentioned |
| Contraindication screening | Baseline hematocrit, PSA, prostate history, cardiovascular history, sleep apnea, thrombophilia | No screening beyond an intake form |
| Monitoring cadence | Levels, hematocrit, PSA and estradiol at 6–12 weeks, then every 6–12 months | Labs only on request, or billed separately each time |
| Delivery flexibility | Injection, cream and pellet trade-offs explained; dose adjusted on response | One modality pushed regardless of fit |
| Exit plan | A stated protocol for tapering, stopping, or restarting endogenous production | No discussion of what happens if you stop |
The fertility item is the one with the least reversibility. Exogenous testosterone suppresses LH and FSH and therefore sperm production, in most men within a few months. Recovery after stopping is common but can take a year or longer and is not guaranteed. A program that never raises the subject has skipped a decision that cannot be revisited later.
The contraindication item runs a close second. Testosterone therapy is not appropriate with active breast or prostate cancer, an unevaluated elevated PSA, baseline hematocrit above roughly 50%, untreated severe sleep apnea, uncontrolled heart failure, a recent cardiovascular event, or a known thrombophilia. None of those is detectable from a symptom questionnaire.
What the total actually costs
Four separate costs make up the bill, and programs bundle them differently. That bundling — not the drug — is what makes advertised pricing hard to compare.
| Cost line | Typical range | Why it moves the total |
|---|---|---|
| Diagnostics | $150–$400 for a full baseline panel; two to four monitoring panels a year | Some programs bundle labs into the fee; others bill each draw. This is the largest source of quoted-price error. |
| Medication | $30–$100/mo generic injectable testosterone; $40–$150 compounded cream; $200–$600 branded oral or nasal; $500–$1,000 per pellet insertion | Almost never included in an advertised membership price. |
| Clinical care | $100–$400/mo for consults, protocol management and messaging | The line that separates programs most. Concierge and imaging-inclusive models sit well above this band. |
| Ancillaries | $0–$150/mo for hCG, anastrozole where genuinely indicated, or a SERM | Frequently added after the first follow-up, so it does not appear in the initial quote. |
What decides whether insurance pays
Insurance covers testosterone therapy when it treats a documented diagnosis of hypogonadism, and does not cover it when it treats symptoms in a man whose levels are within range. That single distinction explains almost every coverage outcome, and it explains why the cash clinics are structured the way they are.
The diagnostic threshold is the gate. Standard practice, reflected in Endocrine Society guidance, is two separate morning total-testosterone measurements below the laboratory reference range, drawn fasting before roughly 10am, alongside consistent symptoms. One low afternoon reading does not establish the diagnosis, and a payer will decline on exactly that basis.
Two practical consequences follow. First, if you are seeking coverage, the sequencing matters: get the two morning draws through a clinician who will document them, before paying a cash program for a convenience panel. Second, a man whose levels sit in the low-normal band is very unlikely to be covered anywhere, which is the population most cash clinics serve.
Medicare. Injectable testosterone administered in a clinic is generally handled under Part B, while self-administered gels, creams and injections fall under a Part D drug plan, subject to that plan's formulary and prior-authorisation rules. Coverage is not automatic in either case and turns on the same documented diagnosis.
VA. The Department of Veterans Affairs prescribes and monitors testosterone through its own primary care and endocrinology pathways for enrolled veterans who meet the diagnostic criteria, which is usually the lowest-cost route available to anyone eligible for it.
Large integrated systems. An HMO-style plan will typically require the diagnosis to be established inside its own network before it will prescribe, so labs bought from a direct-to-consumer platform generally do not substitute for its own draws.
The reason cash programs price at a flat monthly rate is that they are selling the clinician time, the monitoring cadence and the logistics rather than the drug. Testosterone cypionate itself is inexpensive as a generic. When you compare an insured pathway against a cash program, compare total annual cost including every follow-up draw, not the price of the medication.
How to choose
- Decide the scope first. If you want testosterone managed and nothing else, a hormone-focused program is a closer fit and usually cheaper. If you have unresolved metabolic, cardiovascular or thyroid questions alongside the hormone one, a broader program reads them together.
- Check fertility intentions against the pathway. If children are possible in the next several years, a SERM-first or hCG-inclusive protocol changes the conversation, and that narrows the options considerably.
- Compare the panel, not the marketing. Ask for the exact list of markers in the baseline draw. If SHBG, LH, FSH, prolactin and sensitive estradiol are not on it, the pattern cannot be read.
- Ask how often you will be retested and who pays. Monitoring cadence is the single largest driver of annual cost after medication, and it is where quoted prices diverge most from real ones.
- Confirm you can leave. Data portability and outside-pharmacy prescribing both matter more than they appear to at signup.
Some presentations belong with a physician rather than any subscription program: total testosterone under 150 ng/dL, low LH with a very low total, visual field changes or new persistent headaches, nipple discharge, testicular shrinkage or asymmetry, or an abnormal baseline PSA. Each points at a pituitary, testicular or prostate issue that a hormone prescription would obscure rather than treat.
Frequently Asked Questions
What separates a legitimate TRT clinic from a prescription mill?
What happens before the prescription and what happens after it. A legitimate program runs a full baseline panel, confirms low levels on two early-morning draws on separate days, works through reversible causes such as sleep apnea and opioid use, screens contraindications, raises fertility before the first dose, and schedules monitoring at 6–12 weeks. A mill prescribes from one number in one visit and bills monthly. Price and whether the visit is virtual do not decide this — telehealth programs can run rigorous protocols and in-person clinics can run poor ones.
Which platforms offer physician-led hormone care?
The physician-led programs reviewed on this site, listed alphabetically, are Fountain Life, Hone Health, Lifeforce, Marek Health, Maximus and Opt Health. They differ in panel breadth, prescription pathway, retest cadence, whether labs are bundled or billed separately, and price — from roughly $540 a year at the lowest entry tier to $19,500 and above for imaging-inclusive concierge care. Each is reviewed against the same ten-row rubric so the differences are visible side by side.
What are the red flags in a TRT clinic?
A prescription guaranteed before any lab is drawn. A panel with no SHBG, LH or sensitive estradiol. A single afternoon draw. No baseline PSA or hematocrit. One delivery method presented as the only option. No stated monitoring schedule. No mention of fertility. Marketing built on physique transformation rather than measured outcomes. Any one of these is a reason to ask more questions; three of them together describe a subscription rather than a clinical service.
Do I need to see a physician in person for TRT?
In most US states, no. Telehealth prescribing of testosterone is permitted, though testosterone is a Schedule III controlled substance and state rules on the initial evaluation vary. What matters more than the setting is whether the protocol includes proper baseline testing, contraindication screening and scheduled monitoring. In-person care has a genuine advantage when a physical examination is needed — testicular examination, gynecomastia assessment, or a prostate check with an abnormal PSA.
How much does TRT actually cost per month?
Generic injectable testosterone cypionate typically runs $30–$100 a month. Clinical care and membership fees run roughly $100–$400 a month depending on the program. Diagnostics add $150–$400 per full panel, two to four times a year, and may or may not be bundled. Most men on a supervised protocol land between $150 and $400 a month all-in. Pellet protocols and imaging-inclusive concierge programs sit above that range.
Will insurance cover TRT?
Sometimes, when documented hypogonadism is on the chart — typically two low morning total testosterone values with symptoms and an appropriate workup. That is another reason the diagnostic sequence matters: a cash-pay clinic that skips the two confirming draws leaves you without the documentation an insurer requires. Most cash-pay optimization programs do not bill insurance at all, though many accept HSA or FSA funds.
Can I switch programs once I have started?
Yes, and it is worth asking two questions before you sign anywhere. First, will they release your full lab history in a usable format? Second, do they write prescriptions to an outside pharmacy of your choice, or only to an affiliated one? A program that keeps both your data and your dispensing in-house makes switching expensive in a way the advertised price does not show.
Related
- Signs of low testosterone — which symptoms track the numbers
- Free vs total testosterone — how SHBG changes the answer
- TRT delivery methods compared — injections, cream and pellets side by side
- TRT side effects and risks — the cardiovascular and prostate evidence, and what a program should monitor
- TRT and fertility — what to settle before starting if children are possible
- Doctor-led options — every physician-supervised platform on one rubric
- Methodology — how prices, hidden costs and scores are verified